Percutaneous radiofrequency ablation of hepatocellular carcinoma in the presence of portal vein thrombosis.
Portal vein thrombosis (PVT) may not be an absolute contraindication for hepatic radiofrequency ablation (RFA). Although the data are sparse, PVT is commonly considered a contraindication to RFA. PVT has actually been described as a complication following RFA. RFA was used to treat a 3.9 x 2.9 cm primary hepatocellular carcinoma (HCC) in a patient with concomitant PVT without complication. RFA can be safely performed in this setting but further studies could clarify this issue.
Imaging Sciences Program, Clinical Center, National Institutes of Health Building 10, Room 1C387, Bethesda, MD 20892, USA.
Ziv
Z
Neeman
Steven K
SK
Libutti
Jay W
JW
Patti
Bradford J
BJ
Wood
D006528:Carcinoma, Hepatocellular / Q000150:complications* / Q000175:diagnosis / Q000601:surgery*; D017115:Catheter Ablation / Q000379:methods; D000075202:Contraindications; D005500:Follow-Up Studies; D006801:Humans; D008113:Liver Neoplasms / Q000150:complications* / Q000175:diagnosis / Q000601:surgery*; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D011169:Portal Vein; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome; D020246:Venous Thrombosis / Q000150:complications*